Insider Trading & Ownership - Kling Douglas F

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kling Douglas F
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-04-15
Sale
2025-04-17
5:41 pm
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
100,000 $0 $0 594,930
(Direct)
View
2025-03-26
Sale
2025-03-28
5:18 pm
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
16,539 $0 $0 60,539
(Direct)
View
2025-03-17
Sale
2025-03-19
5:29 pm
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
100,000 $0 $0 742,181
(Direct)
View
2025-02-18
Sale
2025-02-20
5:24 pm
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
100,000 $0 $0 305,508
(Direct)
View
2025-01-29
Sale
2025-01-31
5:00 pm
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
70,441 $0 $0 509,868
(Direct)
View
2025-01-27
Sale
2025-01-29
5:16 pm
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
129,559 $0 $0 662,557
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-04-15
Exercise
2025-04-17
5:41 pm
N/A
2032-11-22
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
100,000 $0 594,930
(Direct)
View
2025-04-15
Exercise
2025-04-17
5:41 pm
N/A
N/A
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
100,000 $10 594,930
(Direct)
View
2025-03-26
Option Award
2025-03-28
5:18 pm
N/A
N/A
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
16,539 $0 60,539
(Direct)
View
2025-03-26
Exercise
2025-03-28
5:18 pm
N/A
N/A
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
16,539 $0 60,539
(Direct)
View
2025-03-17
Exercise
2025-03-19
5:29 pm
N/A
2031-07-06
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
100,000 $0 742,181
(Direct)
View
2025-03-17
Exercise
2025-03-19
5:29 pm
N/A
N/A
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
11,888 $10 742,181
(Direct)
View
2025-02-18
Exercise
2025-02-20
5:24 pm
N/A
2031-07-06
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
100,000 $0 305,508
(Direct)
View
2025-01-29
Exercise
2025-01-31
5:00 pm
N/A
2031-07-06
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
70,441 $0 509,868
(Direct)
View
2025-01-27
Exercise
2025-01-29
5:16 pm
N/A
2031-07-06
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
129,559 $0 662,557
(Direct)
View
2025-01-07
Option Award
2025-01-07
5:10 pm
N/A
N/A
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
44,000 $0 44,000
(Direct)
View
2025-01-02
Option Award
2025-01-06
5:57 pm
N/A
2035-01-02
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
250,000 $0 250,000
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:21 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
323,771 $0 323,771
(Direct)
View

Ownership
2023-12-29
4:30 pm
N/A
2033-01-01
NewAmsterdam Pharma Co N.V. NAMS Kling Douglas F
Chief Operating Officer
0 $0 1,378,172
(Direct)
View